Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−59.44 USD
−69.63 M USD
0.00 USD
603.62 K
About Jade Biosciences, Inc.
Sector
Industry
CEO
Tom Frohlich
Website
Headquarters
Waltham
Founded
2018
FIGI
BBG00WGHZFH4
Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of JBIO is 11.61 USD — it has increased by 24.80% in the past 24 hours. Watch Jade Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Jade Biosciences, Inc. stocks are traded under the ticker JBIO.
JBIO stock has fallen by −99.62% compared to the previous week, the month change is a −99.59% fall, over the last year Jade Biosciences, Inc. has showed a −99.95% decrease.
We've gathered analysts' opinions on Jade Biosciences, Inc. future price: according to them, JBIO price has a max estimate of 105.00 USD and a min estimate of 19.00 USD. Watch JBIO chart and read a more detailed Jade Biosciences, Inc. stock forecast: see what analysts think of Jade Biosciences, Inc. and suggest that you do with its stocks.
JBIO reached its all-time high on Apr 1, 2024 with the price of 39,708.38 USD, and its all-time low was 9.02 USD and was reached on May 1, 2025. View more price dynamics on JBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
JBIO stock is 13.82% volatile and has beta coefficient of −0.41. Track Jade Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Jade Biosciences, Inc. there?
Yes, you can track Jade Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Jade Biosciences, Inc. is going to release the next earnings report on Aug 11, 2025. Keep track of upcoming events with our Earnings Calendar.
JBIO net income for the last quarter is −2.52 M USD, while the quarter before that showed −5.43 M USD of net income which accounts for 53.63% change. Track more Jade Biosciences, Inc. financial stats to get the full picture.
As of May 5, 2025, the company has 30 employees. See our rating of the largest employees — is Jade Biosciences, Inc. on this list?
Like other stocks, JBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jade Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Jade Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Jade Biosciences, Inc. stock shows the strong sell signal. See more of Jade Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.